November 12, 2026: Think Tank on Advancing Precision Medicine in Rare Cancers Learn more and register.×

Foundation Medicine CEO Brian Alexander, MD, on the important takeaways from the TRACK Study.

Dr. Brian Alexander, CEO of Foundation Medicine, discusses the important takeaways from TRACK, as well as potential discoveries emerging from it.